Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2024 Filed May 23, 2024 23:02 UTC |
Nissenson AllenDirector
|
GrantCommon Stock | 36,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-064810 · tm2415466-1_4seq1.xml · nonDerivative · entry 1 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,597 F1 · kind: Restricted stock units vest on May 21, 2025, subject to the Reporting Person's continued service to the Issuer. F2 · balance_after: Effective on May 13, 2022, the Issuer effected a 1-for-11 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split. Read SEC document |
| March 17, 2024 Filed Mar 19, 2024 20:33 UTC |
Strobeck MarkDirector · President and CEO
|
Tax withholdingCommon Stock | 6,101 | $1.40 | $8,541.40 |
DisclosureSEC source: 0001104659-24-036181 · tm249266-2_4seq1.xml · nonDerivative · entry 1 Strobeck Mark · CIK 0001599219 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,364 F1 · kind: These shares were withheld from the vesting of restricted stock units to cover the estimated tax withholding obligation. Read SEC document |
| March 17, 2024 Filed Mar 19, 2024 20:30 UTC |
TIMMINS MEGAN C.EVP, CLO and Secretary
|
Tax withholdingCommon Stock | 3,137 | $1.40 | $4,391.80 |
DisclosureSEC source: 0001104659-24-036176 · tm249266-1_4seq1.xml · nonDerivative · entry 1 TIMMINS MEGAN C. · CIK 0001733798 · EVP, CLO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,378 F1 · kind: These shares were withheld from the vesting of restricted stock units to cover the estimated tax withholding obligation. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 20:35 UTC |
Neri JesseSVP, FINANCE
|
GrantStock Option (Right to Buy) · Derivative | 47,190 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001104659-24-035046 · tm248985-3_4seq1.xml · derivative · entry 2 Neri Jesse · CIK 0001997116 · SVP, FINANCE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,190 Underlying: Common Stock · 47,190 shares Expires 2034-03-14 F2 · derivative.exercise_date: Stock options vest 25% on the first anniversary of March 14, 2024, with the remainder vesting in equal monthly installments through March 14, 2028, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 20:35 UTC |
Neri JesseSVP, FINANCE
|
GrantCommon Stock | 33,330 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-035046 · tm248985-3_4seq1.xml · nonDerivative · entry 1 Neri Jesse · CIK 0001997116 · SVP, FINANCE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,330 F1 · kind: Restricted stock units vest in three equal installments on the first, second and third anniversaries of March 14, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 20:34 UTC |
Strobeck MarkDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 141,560 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001104659-24-035044 · tm248985-2_4seq1.xml · derivative · entry 2 Strobeck Mark · CIK 0001599219 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,560 Underlying: Common Stock · 141,560 shares Expires 2034-03-14 F2 · derivative.exercise_date: Stock options vest 25% on the first anniversary of March 14, 2024, with the remainder vesting in equal monthly installments through March 14, 2028, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 20:34 UTC |
Strobeck MarkDirector · President and CEO
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-035044 · tm248985-2_4seq1.xml · nonDerivative · entry 1 Strobeck Mark · CIK 0001599219 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,465 F1 · kind: Restricted stock units vest in three equal installments on the first, second and third anniversaries of March 14, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 20:32 UTC |
TIMMINS MEGAN C.EVP, CLO and Secretary
|
GrantStock Option (Right to Buy) · Derivative | 70,780 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001104659-24-035040 · tm248985-1_4seq1.xml · derivative · entry 2 TIMMINS MEGAN C. · CIK 0001733798 · EVP, CLO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,780 Underlying: Common Stock · 70,780 shares Expires 2034-03-14 F2 · derivative.exercise_date: Stock options vest 25% on the first anniversary of March 14, 2024, with the remainder vesting in equal monthly installments through March 14, 2028, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 20:32 UTC |
TIMMINS MEGAN C.EVP, CLO and Secretary
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-035040 · tm248985-1_4seq1.xml · nonDerivative · entry 1 TIMMINS MEGAN C. · CIK 0001733798 · EVP, CLO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,515 F1 · kind: Restricted stock units vest in three equal installments on the first, second and third anniversaries of March 14, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| October 16, 2023 Filed Oct 18, 2023 10:18 UTC |
Neri JesseSVP, FINANCE
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001104659-23-109744 · tm2328668-4_4seq1.xml · derivative · entry 1 Neri Jesse · CIK 0001997116 · SVP, FINANCE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2033-10-16 F1 · derivative.exercise_date: Stock options vest in four equal installments on the first, second, third and fourth anniversaries of October 16, 2023, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| October 16, 2023 Filed Oct 18, 2023 10:17 UTC |
Lau JoanDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001104659-23-109742 · tm2328668-3_4seq1.xml · derivative · entry 2 Lau Joan · CIK 0001881621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2033-10-16 F2 · derivative.exercise_date: Stock options vest on October 16, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| October 16, 2023 Filed Oct 18, 2023 10:17 UTC |
Lau JoanDirector
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-109742 · tm2328668-3_4seq1.xml · nonDerivative · entry 1 Lau Joan · CIK 0001881621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 F1 · kind: Restricted stock units vest on October 16, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| October 16, 2023 Filed Feb 6, 2024 23:56 UTC Amendment |
Lau JoanDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001104659-24-011215 · tm245360-2_4aseq1.xml · derivative · entry 2 Lau Joan · CIK 0001881621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2033-10-16 F2 · derivative.exercise_date: Stock options vest on October 16, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| October 16, 2023 Filed Feb 6, 2024 23:56 UTC Amendment |
Lau JoanDirector
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-011215 · tm245360-2_4aseq1.xml · nonDerivative · entry 1 Lau Joan · CIK 0001881621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,000 F1 · kind: Restricted stock units vest on October 16, 2024, subject to the Reporting Person's continued service to the Issuer. F3 · balance_after: This Form 4 Amendment is being filed solely to report 2,000 shares that were inadvertently omitted from the Form 4 filed by the Reporting Person on October 18, 2023. Read SEC document |
| May 23, 2023 Filed May 25, 2023 16:14 UTC |
RAVICH MARK HDirector
|
GrantCommon Stock | 24,715 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-064632 · tm2316982-2_4seq1.xml · nonDerivative · entry 1 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 303,319 F1 · kind: Restricted stock units vest on May 23, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:23 UTC |
Smiley Andrea HeslinDirector
|
GrantCommon Stock | 24,715 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-064642 · tm2316982-5_4seq1.xml · nonDerivative · entry 1 Smiley Andrea Heslin · CIK 0001703767 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,316 F1 · kind: Restricted stock units vest on May 23, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:19 UTC |
Radie Robert SDirector
|
GrantCommon Stock | 24,715 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-064639 · tm2316982-4_4seq1.xml · nonDerivative · entry 1 Radie Robert S · CIK 0001591113 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,404 F1 · kind: Restricted stock units vest on May 23, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:18 UTC |
Nissenson AllenDirector
|
GrantCommon Stock | 24,715 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-064638 · tm2316982-3_4seq1.xml · nonDerivative · entry 1 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,203 F1 · kind: Restricted stock units vest on May 23, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:12 UTC |
COOPER JOHN GDirector
|
GrantCommon Stock | 24,715 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-064627 · tm2316982-1_4seq1.xml · nonDerivative · entry 1 COOPER JOHN G · CIK 0001164287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,594 F1 · kind: Restricted stock units vest on May 23, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 22:41 UTC |
TIMMINS MEGAN C.EVP, CLO and Secretary
|
GrantCommon Stock | 28,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-035195 · tm2310125-4_4seq1.xml · nonDerivative · entry 1 TIMMINS MEGAN C. · CIK 0001733798 · EVP, CLO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,515 F1 · kind: Restricted stock units ("RSUs") vest in two equal installments on the first and second anniversaries of March 17, 2023, subject to the Reporting Person's continued service to the Issuer. RSUs are also subject to stockholder approval of an increase in the share reserve under the Rockwell Medical, Inc. Amended and Restated 2018 Long Term Incentive Plan at the 2023 annual meeting of stockholders. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 22:39 UTC |
Hoffman Marc LChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 32,990 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001104659-23-035192 · tm2310125-3_4seq1.xml · derivative · entry 2 Hoffman Marc L · CIK 0001795312 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,990 Underlying: Common Stock · 32,990 shares Expires 2033-03-17 F2 · derivative.exercise_date: Stock options vest 25% on the first anniversary of March 17, 2023, with the remainder vesting in equal monthly installments through March 17, 2027, subject to the Reporting Person's continued service to the Issuer. Stock options are also subject to stockholder approval of an increase in the share reserve under the Rockwell Medical, Inc. Amended and Restated 2018 Long Term Incentive Plan at the 2023 annual meeting of stockholders. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 22:39 UTC |
Hoffman Marc LChief Medical Officer
|
GrantCommon Stock | 25,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-035192 · tm2310125-3_4seq1.xml · nonDerivative · entry 1 Hoffman Marc L · CIK 0001795312 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,665 F1 · kind: Restricted stock units ("RSUs") vest in two equal installments on the first and second anniversaries of March 17, 2023, subject to the Reporting Person's continued service to the Issuer. RSUs are also subject to stockholder approval of an increase in the share reserve under the Rockwell Medical, Inc. Amended and Restated 2018 Long Term Incentive Plan at the 2023 annual meeting of stockholders. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 22:36 UTC |
Strobeck MarkDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 77,105 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001104659-23-035190 · tm2310125-1_4seq1.xml · derivative · entry 2 Strobeck Mark · CIK 0001599219 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,105 Underlying: Common Stock · 77,105 shares Expires 2033-03-17 F2 · derivative.exercise_date: Stock options vest 25% on the first anniversary of March 17, 2023, with the remainder vesting in equal monthly installments through March 17, 2027, subject to the Reporting Person's continued service to the Issuer. Stock options are also subject to stockholder approval of an increase in the share reserve under the Rockwell Medical, Inc. Amended and Restated 2018 Long Term Incentive Plan at the 2023 annual meeting of stockholders. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 22:36 UTC |
Strobeck MarkDirector · President and CEO
|
GrantCommon Stock | 55,465 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-035190 · tm2310125-1_4seq1.xml · nonDerivative · entry 1 Strobeck Mark · CIK 0001599219 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,465 F1 · kind: Restricted stock units ("RSUs") vest in two equal installments on the first and second anniversaries of March 17, 2023, subject to the Reporting Person's continued service to the Issuer. RSUs are also subject to stockholder approval of an increase in the share reserve under the Rockwell Medical, Inc. Amended and Restated 2018 Long Term Incentive Plan at the 2023 annual meeting of stockholders. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 22:33 UTC |
McGarry Paul ESVP, Finance and CAO
|
GrantStock Option (Right to Buy) · Derivative | 37,210 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001104659-23-035187 · tm2310125-2_4seq1.xml · derivative · entry 2 McGarry Paul E · CIK 0001780044 · SVP, Finance and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,210 Underlying: Common Stock · 37,210 shares Expires 2033-03-17 F2 · derivative.exercise_date: Stock options vest 25% on the first anniversary of March 17, 2023, with the remainder vesting in equal monthly installments through March 17, 2027, subject to the Reporting Person's continued service to the Issuer. Stock options are also subject to stockholder approval of an increase in the share reserve under the Rockwell Medical, Inc. Amended and Restated 2018 Long Term Incentive Plan at the 2023 annual meeting of stockholders. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 22:33 UTC |
McGarry Paul ESVP, Finance and CAO
|
GrantCommon Stock | 28,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-035187 · tm2310125-2_4seq1.xml · nonDerivative · entry 1 McGarry Paul E · CIK 0001780044 · SVP, Finance and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,515 F1 · kind: Restricted stock units ("RSUs") vest in two equal installments on the first and second anniversaries of March 17, 2023, subject to the Reporting Person's continued service to the Issuer. RSUs are also subject to stockholder approval of an increase in the share reserve under the Rockwell Medical, Inc. Amended and Restated 2018 Long Term Incentive Plan at the 2023 annual meeting of stockholders. Read SEC document |
| September 09, 2022 Filed Sep 13, 2022 20:33 UTC |
Hoffman Marc LChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $1.66 | $0.00 |
DisclosureSEC source: 0001104659-22-099664 · tm2225800-4_4seq1.xml · derivative · entry 1 Hoffman Marc L · CIK 0001795312 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2032-09-09 F1 · derivative.exercise_date: Stock options vest in four equal installments on the first, second, third and fourth anniversaries of September 9, 2022, subject to the Reporting Person's continued employment with the Issuer. Read SEC document |
| September 09, 2022 Filed Sep 13, 2022 20:32 UTC |
TIMMINS MEGAN C.SVP, General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $1.66 | $0.00 |
DisclosureSEC source: 0001104659-22-099662 · tm2225800-3_4seq1.xml · derivative · entry 1 TIMMINS MEGAN C. · CIK 0001733798 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2032-09-09 F1 · derivative.exercise_date: Stock options vest in four equal installments on the first, second, third and fourth anniversaries of September 9, 2022, subject to the Reporting Person's continued employment with the Issuer. Read SEC document |
| September 09, 2022 Filed Sep 13, 2022 20:31 UTC |
McGarry Paul EVP, Finance
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $1.66 | $0.00 |
DisclosureSEC source: 0001104659-22-099658 · tm2225800-2_4seq1.xml · derivative · entry 1 McGarry Paul E · CIK 0001780044 · VP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2032-09-09 F1 · derivative.exercise_date: Stock options vest in four equal installments on the first, second, third and fourth anniversaries of September 9, 2022, subject to the Reporting Person's continued employment with the Issuer. Read SEC document |
| September 09, 2022 Filed Sep 13, 2022 20:30 UTC |
SKIBSTED RUSSELLSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $1.66 | $0.00 |
DisclosureSEC source: 0001104659-22-099655 · tm2225800-1_4seq1.xml · derivative · entry 1 SKIBSTED RUSSELL · CIK 0001308105 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2032-09-09 F1 · derivative.exercise_date: Stock options vest in four equal installments on the first, second, third and fourth anniversaries of September 9, 2022, subject to the Reporting Person's continued employment with the Issuer. Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 20:37 UTC |
Strobeck MarkDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 400,000 | $0.00 Strike: $1.28 | $0.00 |
DisclosureSEC source: 0001104659-22-077393 · tm2220421-2_4seq1.xml · derivative · entry 1 Strobeck Mark · CIK 0001599219 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2032-07-01 F1 · derivative.exercise_date: Stock options vest in four equal installments on the first, second, third and fourth anniversaries of July 1, 2022. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 16:36 UTC |
RAVICH MARK HDirector
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-069689 · tm2218111-4_4seq1.xml · nonDerivative · entry 1 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,604 F1 · kind: Restricted stock units vest on June 7, 2023, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 20:34 UTC |
COOPER JOHN GDirector
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-069688 · tm2218111-3_4seq1.xml · nonDerivative · entry 1 COOPER JOHN G · CIK 0001164287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,879 F1 · kind: Restricted stock units vest on June 7, 2023, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 20:38 UTC |
Radie Robert SDirector
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-069690 · tm2218111-5_4seq1.xml · nonDerivative · entry 1 Radie Robert S · CIK 0001591113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,689 F1 · kind: Restricted stock units vest on June 7, 2023, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 20:32 UTC |
Smiley Andrea HeslinDirector
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-069684 · tm2218111-2_4seq1.xml · nonDerivative · entry 1 Smiley Andrea Heslin · CIK 0001703767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,601 F1 · kind: Restricted stock units vest on June 7, 2023, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 20:30 UTC |
Nissenson AllenDirector
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-069681 · tm2218111-1_4seq1.xml · nonDerivative · entry 1 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,488 F1 · kind: Restricted stock units vest on June 7, 2023, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| March 17, 2022 Filed Mar 21, 2023 22:41 UTC |
TIMMINS MEGAN C.EVP, CLO and Secretary
|
GrantStock Option (Right to Buy) · Derivative | 37,210 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001104659-23-035195 · tm2310125-4_4seq1.xml · derivative · entry 2 TIMMINS MEGAN C. · CIK 0001733798 · EVP, CLO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,210 Underlying: Common Stock · 37,210 shares Expires 2033-03-17 F2 · derivative.exercise_date: Stock options vest 25% on the first anniversary of March 17, 2023, with the remainder vesting in equal monthly installments through March 17, 2027, subject to the Reporting Person's continued service to the Issuer. Stock options are also subject to stockholder approval of an increase in the share reserve under the Rockwell Medical, Inc. Amended and Restated 2018 Long Term Incentive Plan at the 2023 annual meeting of stockholders. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 21:19 UTC |
TIMMINS MEGAN C.See Remarks
|
GrantStock Option (Right to Buy) · Derivative | 350,000 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001628280-21-017256 · wf-form4_162932155452369.xml · derivative · entry 1 TIMMINS MEGAN C. · CIK 0001733798 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2031-08-16 F1 · derivative.exercise_date: Stock options vest in two equal installments on the second and fourth anniversaries of August 16, 2021. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 17:27 UTC |
RAVICH MARK HDirector
|
GrantStock Option (Right to Buy) · Derivative | 72,857 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001628280-21-012675 · wf-form4_162439722360264.xml · derivative · entry 5 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,857 Underlying: Common Stock · 72,857 shares Expires 2031-06-17 F5 · derivative.exercise_date: Stock options shall vest in accordance with the following vesting schedule: (1) one-half (fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2023; and (2) the final one-half (remaining fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2025, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 17:27 UTC |
RAVICH MARK HDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-012675 · wf-form4_162439722360264.xml · nonDerivative · entry 1 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,604 F1 · kind: Restricted stock units vest on June 17, 2022, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:26 UTC |
COOPER JOHN GDirector
|
GrantStock Option (Right to Buy) · Derivative | 72,857 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001628280-21-012672 · wf-form4_162439717772606.xml · derivative · entry 2 COOPER JOHN G · CIK 0001164287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,857 Underlying: Common Stock · 72,857 shares Expires 2031-06-17 F2 · derivative.exercise_date: Stock options shall vest in accordance with the following vesting schedule: (1) one-half (fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2023; and (2) the final one-half (remaining fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2025, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:26 UTC |
COOPER JOHN GDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-012672 · wf-form4_162439717772606.xml · nonDerivative · entry 1 COOPER JOHN G · CIK 0001164287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,879 F1 · kind: Restricted stock units vest on June 17, 2022, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:26 UTC |
Smiley Andrea HeslinDirector
|
GrantStock Option (Right to Buy) · Derivative | 72,857 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001628280-21-012671 · wf-form4_162439714172479.xml · derivative · entry 2 Smiley Andrea Heslin · CIK 0001703767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,857 Underlying: Common Stock · 72,857 shares Expires 2031-06-17 F3 · derivative.exercise_date: Stock options shall vest in accordance with the following vesting schedule: (1) one-half (fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2023; and (2) the final one-half (remaining fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2025, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:26 UTC |
Smiley Andrea HeslinDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-012671 · wf-form4_162439714172479.xml · nonDerivative · entry 1 Smiley Andrea Heslin · CIK 0001703767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,601 F1 · kind: Restricted stock units vest on June 17, 2022, subject to the Reporting Person's continued service to the Issuer. F2 · balance_after: Includes 18,601 shares of common stock underlying unvested restricted stock units that vest on December 11, 2021, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:25 UTC |
Radie Robert SDirector
|
GrantStock Option (Right to Buy) · Derivative | 72,857 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001628280-21-012670 · wf-form4_162439711921121.xml · derivative · entry 2 Radie Robert S · CIK 0001591113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,857 Underlying: Common Stock · 72,857 shares Expires 2031-06-17 F2 · derivative.exercise_date: Stock options shall vest in accordance with the following vesting schedule: (1) one-half (fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2023; and (2) the final one-half (remaining fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2025, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:25 UTC |
Radie Robert SDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-012670 · wf-form4_162439711921121.xml · nonDerivative · entry 1 Radie Robert S · CIK 0001591113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,689 F1 · kind: Restricted stock units vest on June 17, 2022, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:25 UTC |
MCLAUGHLIN JOHN PETERDirector
|
GrantStock Option (Right to Buy) · Derivative | 72,857 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001628280-21-012668 · wf-form4_162439706590346.xml · derivative · entry 2 MCLAUGHLIN JOHN PETER · CIK 0001277967 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,857 Underlying: Common Stock · 72,857 shares Expires 2031-06-17 F2 · derivative.exercise_date: Stock options shall vest in accordance with the following vesting schedule: (1) one-half (fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2023; and (2) the final one-half (remaining fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2025, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:25 UTC |
MCLAUGHLIN JOHN PETERDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-012668 · wf-form4_162439706590346.xml · nonDerivative · entry 1 MCLAUGHLIN JOHN PETER · CIK 0001277967 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,974 F1 · kind: Restricted stock units vest on June 17, 2022, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:24 UTC |
Nissenson AllenDirector
|
GrantStock Option (Right to Buy) · Derivative | 72,857 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001628280-21-012667 · wf-form4_162439703839034.xml · derivative · entry 2 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,857 Underlying: Common Stock · 72,857 shares Expires 2031-06-17 F3 · derivative.exercise_date: Stock options shall vest in accordance with the following vesting schedule: (1) one-half (fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2023; and (2) the final one-half (remaining fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2025, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:24 UTC |
Nissenson AllenDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-012667 · wf-form4_162439703839034.xml · nonDerivative · entry 1 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,488 F1 · kind: Restricted stock units vest on June 17, 2022, subject to the Reporting Person's continued service to the Issuer. F2 · balance_after: Includes 1,488 shares of common stock underlying unvested restricted stock units that vest on December 11, 2021, subject to the Reporting Person's continued service to the issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.